tiprankstipranks
Moderna price target lowered to $45 from $55 at Bernstein
The Fly

Moderna price target lowered to $45 from $55 at Bernstein

Bernstein lowered the firm’s price target on Moderna (MRNA) to $45 from $55 and keeps a Market Perform rating on the shares. The firm cites the new lowered revenue trajectory especially in 2025 and challenge to maintain operating margins with revenue volatility.

Invest with Confidence:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App